Literature DB >> 26177979

The Effects of Arterial Hypertension and Age on the Sublingual Microcirculation of Healthy Volunteers and Outpatients with Cardiovascular Risk Factors.

Vanina S Kanoore Edul1,2,3, Can Ince3, Elisa Estenssoro4, Gonzalo Ferrara1,4, Yanina Arzani5, Carolina Salvatori6, Arnaldo Dubin1,6.   

Abstract

OBJECTIVES: To quantitatively assess the effects of age, blood pressure, chronic arterial hypertension, and physical activity on sublingual microcirculation in ambulatory volunteers.
METHODS: Sublingual microcirculation was assessed in 61 volunteers with or without chronic arterial hypertension.
RESULTS: Volunteers with chronic arterial hypertension had lower TVD all vessels, and TVD small vessels and PVD small vessels than those without this condition (16.0 ± 1.4 vs. 17.2 ± 1.6 mm/mm(2), p < 0.01, 15.1 ± 1.3 vs. 16.1 ± 1.7 mm/mm(2), p < 0.04, and 15.1 ± 1.3 vs. 16.1 ± 1.7 mm/mm(2), p < 0.04, respectively). Mean blood pressure correlated with TVD all vessels (r = -0.34, p < 0.01), TVD small vessels (r = -0.31, p < 0.02), and PVD small vessels (r = -0.27, p < 0.04) but not with other microvascular variables. Age was not correlated with any microcirculatory variables. Physical activity correlated with TVDall vessels and RBCV small vessels (r = 0.30, p < 0.02 and r = -0.47, p < 0.001, respectively). Chronic arterial hypertension was the only independent determinant of PVD small vessels .
CONCLUSIONS: Preexistent chronic arterial hypertension was associated with lower vascular densities. In contrast, age showed no effect on sublingual microcirculation.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  age; chronic arterial hypertension; exercise; sublingual microcirculation

Mesh:

Year:  2015        PMID: 26177979     DOI: 10.1111/micc.12219

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  6 in total

1.  Recruitment of non-perfused sublingual capillaries increases microcirculatory oxygen extraction capacity throughout ascent to 7126 m.

Authors:  Matthias Peter Hilty; Tobias Michael Merz; Urs Hefti; Can Ince; Marco Maggiorini; Jacqueline Pichler Hefti
Journal:  J Physiol       Date:  2019-03-28       Impact factor: 5.182

2.  Variations in pulp volume between normotensive and hypertensive individuals on CBCT imaging.

Authors:  Amanda Farias Gomes; Saulo L Sousa Melo; Yuri Nejaim; Francisco Carlos Groppo; Fabrício B Teixeira; Deborah Queiroz Freitas
Journal:  Clin Oral Investig       Date:  2020-04-24       Impact factor: 3.573

3.  Second consensus on the assessment of sublingual microcirculation in critically ill patients: results from a task force of the European Society of Intensive Care Medicine.

Authors:  Can Ince; E Christiaan Boerma; Maurizio Cecconi; Daniel De Backer; Nathan I Shapiro; Jacques Duranteau; Michael R Pinsky; Antonio Artigas; Jean-Louis Teboul; Irwin K M Reiss; Cesar Aldecoa; Sam D Hutchings; Abele Donati; Marco Maggiorini; Fabio S Taccone; Glenn Hernandez; Didier Payen; Dick Tibboel; Daniel S Martin; Alexander Zarbock; Xavier Monnet; Arnaldo Dubin; Jan Bakker; Jean-Louis Vincent; Thomas W L Scheeren
Journal:  Intensive Care Med       Date:  2018-02-06       Impact factor: 17.440

4.  Patients with chronic mesenteric ischemia have an altered sublingual microcirculation.

Authors:  Jihan Harki; Mustafa Suker; M Sherezade Tovar-Doncel; Louisa Jd van Dijk; Désirée van Noord; Casper Hj van Eijck; Marco J Bruno; Ernst J Kuipers; Can Ince
Journal:  Clin Exp Gastroenterol       Date:  2018-10-18

Review 5.  Monitoring Microcirculation: Utility and Barriers - A Point-of-View Review.

Authors:  Arnaldo Dubin; Vanina Siham Kanoore Edul; Juan Francisco Caminos Eguillor; Gonzalo Ferrara
Journal:  Vasc Health Risk Manag       Date:  2020-12-31

6.  Relationship of Effective Circulating Volume with Sublingual Red Blood Cell Velocity and Microvessel Pressure Difference: A Clinical Investigation and Computational Fluid Dynamics Modeling.

Authors:  Athanasios Chalkias; Michalis Xenos
Journal:  J Clin Med       Date:  2022-08-20       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.